Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

• Главные авторы: Matthias Eder (Автор), Oliver Neels (Автор), Miriam Müller (Автор), Ulrike Bauder-Wüst (Автор), Yvonne Remde (Автор), Martin Schäfer (Автор), Ute Hennrich (Автор), Michael Eisenhut (Автор), Ali Afshar-Oromieh (Автор), Uwe Haberkorn (Автор), Klaus Kopka (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2014-06-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last years. 68Ga-labelled Glu-urea-Lys(Ahx)-HBED-CC ([68Ga]Ga-PSMA-HBED-CC) represents a successful novel PSMA inhibitor radiotracer which has recent...